These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25498892)

  • 1. Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophrenia.
    Zugno AI; Chipindo H; Canever L; Budni J; Alves de Castro A; Bittencourt de Oliveira M; Heylmann AS; Gomes Wessler P; da Rosa Silveira F; Damázio LS; Mastella GA; Kist LW; Bogo MR; Quevedo J; Gama CS
    Life Sci; 2015 Jan; 121():65-9. PubMed ID: 25498892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia.
    Zugno AI; Matos MP; Canever L; Fraga DB; De Luca RD; Ghedim FV; Deroza PF; de Oliveira MB; Pacheco FD; Valvassori SS; Volpato AM; Budni J; Quevedo J
    Acta Neuropsychiatr; 2014 Feb; 26(1):43-50. PubMed ID: 25142099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.
    Damazio LS; Silveira FR; Canever L; Castro AA; Estrela JM; Budni J; Zugno AI
    An Acad Bras Cienc; 2017; 89(2):1133-1141. PubMed ID: 28513779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
    Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
    Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
    Zugno AI; Julião RF; Budni J; Volpato AM; Fraga DB; Pacheco FD; Deroza PF; Luca RD; de Oliveira MB; Heylmann AS; Quevedo J
    Metab Brain Dis; 2013 Sep; 28(3):501-8. PubMed ID: 23775300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maternal deprivation on acetylcholinesterase activity and behavioral changes on the ketamine-induced animal model of schizophrenia.
    Zugno AI; de Miranda IM; Budni J; Volpato AM; Luca RD; Deroza PF; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Wessler P; Antunes Mastella G; Cipriano AL; Quevedo J
    Neuroscience; 2013 Sep; 248():252-60. PubMed ID: 23769892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of omega-3 supplementation on interleukin and neurotrophin levels in an animal model of schizophrenia.
    Zugno AI; Canever L; Mastella G; Heylmann AS; Oliveira MB; Steckert AV; Castro AA; dal Pizzol F; Quevedo J; Gama CS
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1475-86. PubMed ID: 26397829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical investigation of Diabetes Mellitus as a risk factor for schizophrenia.
    Heylmann ASA; Canever L; Gress K; Gomes ST; Fachim I; Michels C; Stopassoli GC; Mastella GA; Steckert AV; Damiani AP; de Andrade VM; Quevedo J; Zugno AI
    Behav Brain Res; 2017 May; 326():154-164. PubMed ID: 28286284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex.
    Usun Y; Eybrard S; Meyer F; Louilot A
    Behav Brain Res; 2013 Nov; 256():229-37. PubMed ID: 23958806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of developing schizophrenia in animals exposed to cigarette smoke during the gestational period.
    Zugno AI; Oliveira MB; Mastella GA; Heylmann ASA; Canever L; Pacheco FD; Damazio LS; Citadin SA; de Lucca LA; Simões LR; Malgarin F; Budni J; Barichello T; Schuck PF; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():199-206. PubMed ID: 28229913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of acetylcholinesterase in an animal model of mania induced by D-amphetamine.
    Varela RB; Valvassori SS; Lopes-Borges J; Fraga DB; Resende WR; Arent CO; Zugno AI; Quevedo J
    Psychiatry Res; 2013 Sep; 209(2):229-34. PubMed ID: 23245536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine Affects the Expression of ErbB4 in the Hippocampus and Prefrontal Cortex of Rats.
    Xie R; Hong S; Ye Y; Wang X; Chen F; Yang L; Yan Y; Liao L
    J Mol Neurosci; 2020 Jun; 70(6):962-967. PubMed ID: 32096126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
    Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
    Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acute severe monocrotophos poisoning on inhibition, expression and activity of acetylcholinesterase in different rat brain regions.
    Kazi AI; Oommen A
    Neurotoxicology; 2012 Oct; 33(5):1284-90. PubMed ID: 22903060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effects of omega-3 fatty acid against toluene-induced neurotoxicity in prefrontal cortex of rats.
    Meydan S; Altas M; Nacar A; Ozturk OH; Tas U; Zararsiz I; Sarsilmaz M
    Hum Exp Toxicol; 2012 Nov; 31(11):1179-85. PubMed ID: 23079668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of omega-3 essential fatty acids against formaldehyde-induced neuronal damage in prefrontal cortex of rats.
    Zararsiz I; Kus I; Akpolat N; Songur A; Ogeturk M; Sarsilmaz M
    Cell Biochem Funct; 2006; 24(3):237-44. PubMed ID: 15648056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant and acetylcholinesterase response to repeated malathion exposure in rat cerebral cortex and hippocampus.
    Trevisan R; Uliano-Silva M; Pandolfo P; Franco JL; Brocardo PS; Santos AR; Farina M; Rodrigues AL; Takahashi RN; Dafre AL
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):365-9. PubMed ID: 18341513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.
    Razoux F; Garcia R; Léna I
    Neuropsychopharmacology; 2007 Mar; 32(3):719-27. PubMed ID: 16525415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.